Classification
Compound class	Peptide or derivative
Approved drug?	Yes (source: FDA (2014))

Comments

AlprolixTM is a recombinant fusion protein combining the peptide for coagulation factor IX with an antibody Fc domain. The presence of the Fc domain increases protein half-life and extends the drug's therapeutic window.